Paul Dicandeloro currently serves as the Senior Director of Business Development at AGC Biologics, a leading Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapies. In this pivotal role, Paul leverages his extensive expertise in protein biochemistry, molecular biology, and bioinformatics to...
Paul Dicandeloro currently serves as the Senior Director of Business Development at AGC Biologics, a leading Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapies. In this pivotal role, Paul leverages his extensive expertise in protein biochemistry, molecular biology, and bioinformatics to drive strategic initiatives that enhance AGC Biologics' portfolio of services for viral vectors and cell therapies. His deep understanding of assay development and gene expression profiling allows him to effectively communicate the value of AGC's capabilities to potential partners, ensuring alignment with their therapeutic goals.
Under Paul's leadership, key projects have focused on optimizing the manufacturing processes for complex biologics, including the development of robust purification strategies using advanced chromatography techniques. His proficiency in enzymology and protein chemistry has been instrumental in streamlining workflows, improving yield, and maintaining the integrity of sensitive biological materials. By fostering collaboration between cross-functional teams, Paul ensures that AGC Biologics remains at the forefront of innovation in the rapidly evolving landscape of cell and gene therapies.
In addition to his technical skills, Paul is adept at navigating the regulatory complexities associated with biopharmaceutical development. His insights into drug discovery and cell culture methodologies position him as a trusted advisor to clients seeking to advance their therapeutic candidates from concept to commercialization. With a commitment to excellence and a passion for scientific advancement, Paul Dicandeloro is a key driver of growth and innovation at AGC Biologics, helping to shape the future of transformative therapies in the biopharmaceutical industry.
